Eberhard Karls Universität Tübingen

Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO/ARO/AIO-16): an open-label, multicentre, single-arm, phase 2 trial (2025) Gani C, Fokas E, Polat B, Ott O, Diefenhardt M, Königsrainer A, Böke S, et al. Journal article Cluster analyses of contemporary embalming protocols in central European anatomy institutions: A collaborative effort to minimize chemical exposure (2025) Mohebimoushaei S, Antipova V, Biedermann U, Brand-Saberi B, Bräuer L, Caspers S, Doll S, et al. Journal article Capturing the Complex: An Intraindividual Temporal Network Analysis of Learning Resource Regulation (2025) Harder B, Naujoks-Schober N, Hopp MD Journal article Modifying exercise and physical therapy in medical rehabilitation to promote a physically active lifestyle: Protocol for a multicenter controlled hybrid type 2 effectiveness-implementation study in three German rehabilitation centers (2025) Grüne E, Carl J, Geidl W, Popp J, Fiedler DV, Boss N, Brinkmann R, et al. Journal article Kinesin-12 POK2 polarization is a prerequisite for a fully functional division site and aids cell plate positioning (2025) Livanos P, Kriechbaum C, Remers S, Herrmann A, Müller S Journal article, Original article First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: A multicenter study from the prospective skin cancer registry ADOREG (2025) Reinhard S, Utikal JS, Zaremba A, Lodde G, von Wasielewski I, Klespe KC, Meier F, et al. Journal article FlashCam: A high-performance camera for IACTs (2025) Nieves CE, Barcelo M, Bauer C, Bi B, Diebold S, Föhr C, Funk S, et al. Conference contribution EROSITA X-ray analysis of the PeVatron candidate Westerlund 1 (2025) Haubner K, Sasaki M, Mitchell A, Ponti G, Rowell G, Einecke S, Filipović M, et al. Journal article Educational Leadership and Children´s Rights? Kinderrechte als Führungsaufgabe? (2025) Hugo J, Assmann C, Schmidt A Edited Volume Phase i study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma (2025) Eigentler T, Thomas I, Samoylenko I, Erdmann M, Heinzerling L, Ochsenreither S, Krauss J, et al. Journal article